BlackBerry case study

Why BlackBerry Jump 11.51% on 03/31/17? BlackBerry (BBRY) jump 11.51% as a result of positive news signal: Shares of BlackBerry Ltd jump 11.51% on Friday morning after the company reported a $0.04 per share profit in the fourth quarter, marking an improvement from a $0.03 per share loss a year ago. Revenue for the quarter was [...]

By | March 31st, 2017|case studies, Uncategorized|Comments Off on BlackBerry case study

Extreme Networks case study

Why Extreme Networks Jump 15% on 03/30/17? Extreme Networks (EXTR) jump 15% as a result of positive news signals: Shares of networking hardware company Extreme Networks surged on Thursday after the company announced that it had agreed to acquire the data center technology business of Brocade Communication Systems. Extreme expects the acquired business to generate more [...]

By | March 30th, 2017|case studies, Uncategorized|0 Comments

Tonix Pharmaceuticals case study

Why Tonix Pharmaceuticals Jump 34% on 03/29/17? Tonix Pharmaceuticals (TNXP) jump 34% as a result of two positive news signals: Seth Lederman, M.D., president and chief executive officer of Tonix, will provide a corporate update and an overview of Tonix’s posttraumatic stress disorder (PTSD) clinical program. TNX-102 SL* was recently granted Breakthrough Therapy designation by [...]

By | March 29th, 2017|case studies, Uncategorized|0 Comments

Darden Restaurants case study

Why Darden Restaurants Jump 8% on 03/28/17? Darden Restaurants (DRI) jump 8% as a result of two positive news signals: Shares of Darden Restaurants were gaining by 8% to $81.62 on Tuesday morning, after the restaurant operator announced better than expected 2017 third quarter earnings and that it is buying restaurant brand Cheddar's Scratch Kitchen. The [...]

By | March 28th, 2017|case studies, Uncategorized|0 Comments

Cellect Biotechnology case study

Why Cellect Biotechnology Jump 70% on 03/27/17? Cellect Biotechnology (APOP) jump 70% as a result of positive news signal: Cellect Biotechnology a developer of stem cell selection technology, announced today that the first stem cell transplant procedure has been successfully performed using its ApoGraft™ technology in the Company’s Phase I/II clinical trial in a blood [...]

By | March 27th, 2017|case studies, Uncategorized|0 Comments

HTG Molecular case study

Why HTG Molecular Diagnostics Jump 145% on 03/24/17? HTG Molecular Diagnostics (HTGM) jump 145% as a result of two positive news signal: As we stress in our last HTG Molecular Diagnostics Inc case study and positive long-term signal from the 03/23/17.  HTG Molecular Diagnostics Reports Growth in Fourth Quarter and Full Year 2016 Revenue for [...]

By | March 24th, 2017|case studies, Uncategorized|0 Comments

Sunshine Heart case study

Why Sunshine Heart Jump 14% on 03/23/17? Sunshine Heart (SSH) jump 14% as a result of positive news signal: Sunshine Heart Provides Business Update Regarding Execution of Strategic Growth Plan. The company announced today its progress in successfully executing its Aquadex growth strategy. After acquiring the Aquadex business from Baxter International in August of 2016, [...]

By | March 23rd, 2017|case studies, Uncategorized|0 Comments

HTG Molecular Diagnostics case study

Why HTG Molecular Diagnostics Jump 103% on 03/23/17? HTG Molecular Diagnostics (HTGM) jump 103% as a result of positive news signal: HTG Molecular Diagnostics Inc. saw its shares make a massive move to the upside after the company announced that it has obtained CE Marking in the European Union for its HTG EdgeSeq ALKPlus Assay [...]

By | March 23rd, 2017|case studies, Uncategorized|0 Comments

Moleculin Biotech case study

Why Moleculin Biotech Jump 31% on 03/22/17? Moleculin Biotech (MBRX) jump 31% as a result of positive news signal: Moleculin Receives Orphan Drug Designation for Annamycin for the Treatment of Acute Myeloid Leukemia. The FDA grants orphan drug designation to drugs and biologics that are intended for the treatment of rare diseases that affect fewer [...]

By | March 22nd, 2017|case studies, Uncategorized|0 Comments

Pulmatrix case study

Why Pulmatrix Jump 30% on 03/21/17? Pulmatrix (PULM) jump 30% as a result of positive news signal: Pulmatrix Inc. (PULM) announced that it secured a patent from the European Union for its iSPERSE (inhaled small particles easily respirable and emitted) drug-delivery platform. Based on the dry powder form for enhanced drug delivery through inhalation, the [...]

By | March 21st, 2017|case studies, Uncategorized|0 Comments